Watch The Replay: Redefining iPSC Genome Editing for Next-Generation Cell Therapies

Published on November 24, 2025
CELL_Ft image_Watch the webinar iPSC genome editing

In this webinar, we review current approaches for executing complex genome edits at high precision and efficiency, alongside the quality, safety, and regulatory considerations that guide iPSC genome engineering programs for next-generation cell therapies.

Continue reading on website
Other news

Characteristics of EMS 9-1-1 Activations for Pediatric Drownings, a National Cross-Sectional Study

November 21, 2025
About this Research Project Authors: Lindsay Walsh, MD1; Macall Leslie Salewon, MPH2; Rebecca E. Cash, PhD3, Jonathan R. Powell, PhD2; Morgan K. Anderson, MPH2 1Harvard Affiliated Emergency Medicine Residency Program, Department of Emergency Medicine, Mass General Brigham2Clinical and Research Services, ImageTrend3Department of Emergency Medicine, Mass General Brigham, Harvard Medical School   Bac

PharmaSource Podcast: ADC Manufacturing Demand Outpaces Capacity in US Market

November 24, 2025
“Twenty years ago, who knew that ADCs and next-generation bioconjugates were going to be so exciting, so successful?”Campbell Bunce, Chief Scientific Officer at Abzena, reflects on the strategic positioning that has placed his company at the forefront of one of pharma’s fastest-growing segments.Campbell leads a global team spanning discovery, development, and GMP manufacturing at Abzena, where he